Abstract
A recent review and meta-analysis on pharmacotherapy for neuropathic pain provides a precise update on treatment efficacy and adverse effects. The authors offer revised evidence-based recommendations for first-line therapies and subsequent options, but we still a need to improve individual treatment decisions, including nonpharmacological therapies, in affected patients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amines / therapeutic use
-
Analgesics, Opioid / therapeutic use
-
Anticonvulsants / therapeutic use
-
Antidepressive Agents / therapeutic use
-
Cyclohexanecarboxylic Acids / therapeutic use
-
Gabapentin
-
Humans
-
Neuralgia / drug therapy*
-
Randomized Controlled Trials as Topic
-
Tramadol
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Amines
-
Analgesics, Opioid
-
Anticonvulsants
-
Antidepressive Agents
-
Cyclohexanecarboxylic Acids
-
Tramadol
-
gamma-Aminobutyric Acid
-
Gabapentin